Iovance Biotherapeutics (IOVA) Provides Regulatory Update for Lifileucel Potency Assays, BLA Submission Now Expected H1 2022
Go back to Iovance Biotherapeutics (IOVA) Provides Regulatory Update for Lifileucel Potency Assays, BLA Submission Now Expected H1 2022(NASDAQ: IOVA) | Delayed: 11.83 -0.09 (0.76%) | |||||
---|---|---|---|---|---|---|
Previous Close | $11.92 | 52 Week High | $ | |||
Open | $11.96 | 52 Week Low | $ | |||
Day High | $12.12 | P/E | N/A | |||
Day Low | $11.65 | EPS | $ | |||
Volume | 1,610,260 |